ArticleBMC medical imaging2025
Application value of radiomics features based on PSMA PET/CT in diagnosis of clinically significant prostate cancer: a comparison between manual and automatic segmentation.
Article in BMC medical imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundRadiomics shows promise for non-invasive detection of clinically significant prostate cancer (csPCa) using prostate-specific membrane antigen positron emission tomography/computed tomography (PSMA-PET/CT). However, the impact of segmentation method-manual versus automated-on feature reproducibility and diagnostic performance remains unclear.
objectivesTo compare the diagnostic value of radiomics features extracted from manual versus convolutional neural network (CNN)-based segmentations in PSMA-PET/CT for csPCa detection, and to evaluate their performance against maximum standardized uptake value (SUVmax).
methodsRadiomics features (n = 1155) were extracted from both manual and CNN-based (3D U-Net) segmentations in 110 patients. The cohort was split into training and test sets (7:3). Key features were selected using least absolute shrinkage and selection operator (LASSO) regression. Feature consistency between methods was assessed using intraclass correlation coefficient (ICC) and Cohen's kappa. Diagnostic models were built on the training set and validated in the independent test set using area under the receiver operating characteristic curve (AUC) and accuracy (ACC).
resultsOf the 1155 features, 258 (22.24%) showed strong agreement (kappa ≥ 0.7) and 484 (41.90%) moderate agreement (0.4 < kappa < 0.7) between segmentation methods. Among the 10 LASSO-selected features, 4 showed strong and 3 moderate agreement. The CNN-based radiomics model achieved the highest diagnostic performance in the test set (AUC: 0.895, ACC: 0.873), outperforming both the manual model and SUVmax (AUC: 0.822).
conclusionRadiomics features from PSMA-PET/CT offer superior diagnostic performance for csPCa compared to SUVmax. The use of CNN-based segmentation facilitates the development of more efficient, objective, and stable radiomics models, with reduced inter-observer variability and improved reproducibility.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.